The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Bone Microenvironment and Osteosarcoma Metastasis
Open accessAbstract
The bone microenvironment is an ideal fertile soil for both primary and secondary tumors to seed. The occurrence and development of osteosarcoma, as a primary bone tumor, is closely related to the bone microenvironment. Especially, the metastasis of osteosarcoma is the remaining challenge of therapy and poor prognosis. Increasing evidence focuses on the relationship between the bone microenvironment and osteosarcoma metastasis. Many elements exist in the bone microenvironment, such as acids, hypoxia, and chemokines, which have been verified to affect the progression and malignance of osteosarcoma through various signaling pathways. We thoroughly summarized all these regulators in the bone microenvironment and the transmission cascades, accordingly, attempting to furnish hints for inhibiting osteosarcoma metastasis via the amelioration of the bone microenvironment. In addition, analysis of the cross-talk between the bone microenvironment and osteosarcoma will help us to deeply understand the development of osteosarcoma. The cellular and molecular protagonists presented in the bone microenvironment promoting osteosarcoma metastasis will accelerate the exploration of novel therapeutic strategies towards osteosarcoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Jiang, R., Zhang, C., Liu, G., Gu, R., & Wu, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26024 · Cited by 69
RetractedThe Tumor Suppressor Role of miR-124 in Osteosarcoma
Geng, S., Zhang, X., Chen, J., Liu, X., Zhang, H., Xu, X., Ma, Y., Li, B., Zhang, Y., Bi, Z., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091566 · Cited by 63
Self-citationRetractedZhou, Y., Yang, C., Wang, K., Liu, X., & Liu, Q. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14743337535446 · Cited by 43
Self-citationRetractedNotch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393 · cited 1×
“Tumor metastasis is the primary problem for tumor therapy [23].”
BackgroundMirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784 · cited 1×
“The bone microenvironment is also a fertile soil and a complex biological system that facilitates the metastasis of many cancers including osteosarcoma (OS) [8,9].”
BackgroundAdvances in therapeutic applications of extracellular vesicles
Wiklander, O. P. B., Brennan, M. Á., Lötvall, J., Breakefield, X. O., & EL Andaloussi, S. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav8521 · Cited by 1,039
Targeting the Hedgehog pathway in cancer
Rubin, L. L., & de Sauvage, F. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2086 · Cited by 949
The Hedgehog Response Network: Sensors, Switches, and Routers
Lum, L., & Beachy, P. A. (2004) · Science · doi:10.1126/science.1098020 · Cited by 838
Tumor microenvironment: Sanctuary of the devil
Hui, L., & Chen, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.039 · Cited by 779
Homeostatic chemokine receptors and organ-specific metastasis
Zlotnik, A., Burkhardt, A. M., & Homey, B. (2011) · Nature Reviews Immunology · doi:10.1038/nri3049 · Cited by 571
Targeting the microenvironment in solid tumors
Belli, C., Trapani, D., Viale, G., D'Amico, P., Duso, B. A., Della Vigna, P., Orsi, F., & Curigliano, G. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.02.004 · Cited by 496
Walkley, C. R., Qudsi, R., Sankaran, V. G., Perry, J. A., Gostissa, M., Roth, S. I., Rodda, S. J., Snay, E., Dunning, P., Fahey, F. H., et al. (2008) · Genes & Development · doi:10.1101/gad.1656808 · Cited by 373
The Molecular Pathogenesis of Osteosarcoma: A Review
Broadhead, M. L., Clark, J. C. M., Myers, D. E., Dass, C. R., & Choong, P. F. M. (2011) · Sarcoma · doi:10.1155/2011/959248 · Cited by 346
McMahon, S., Charbonneau, M., Grandmont, S., Richard, D. E., & Dubois, C. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604507200 · Cited by 330
PI3K/Akt signaling in osteosarcoma
Zhang, J., Yu, X.-H., Yan, Y.-G., Wang, C., & Wang, W.-J. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.12.041 · Cited by 327
Molecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273
Mohseny, A. B., Szuhai, K., Romeo, S., Buddingh, E. P., Briaire‐de Bruijn, I., de Jong, D., van Pel, M., Cleton‐Jansen, A., & Hogendoorn, P. C. (2009) · The Journal of Pathology · doi:10.1002/path.2603 · Cited by 269
Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage
Berman, S. D., Calo, E., Landman, A. S., Danielian, P. S., Miller, E. S., West, J. C., Fonhoue, B. D., Caron, A., Bronson, R., Bouxsein, M. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805462105 · Cited by 266
Review: Targeting the Hedgehog pathway in cancer
Gupta, S., Takebe, N., & LoRusso, P. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010366430 · Cited by 259
Recent advances in osteosarcoma
Botter, S. M., Neri, D., & Fuchs, B. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.02.002 · Cited by 248
Osteolytic bone metastasis in breast cancer
Yoneda, T., Sasaki, A., & Mundy, G. R. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666208 · Cited by 246
Zhao, G., Cai, C., Yang, T., Qiu, X., Liao, B., Li, W., Ji, Z., Zhao, J., Zhao, H., Guo, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053906 · Cited by 226
Bone microenvironment signals in osteosarcoma development
Alfranca, A., Martinez-Cruzado, L., Tornin, J., Abarrategi, A., Amaral, T., de Alava, E., Menendez, P., Garcia-Castro, J., & Rodriguez, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1918-y · Cited by 223
JAK-STAT signaling in cancer: From cytokines to non-coding genome
Pencik, J., Pham, H. T. T., Schmoellerl, J., Javaheri, T., Schlederer, M., Culig, Z., Merkel, O., Moriggl, R., Grebien, F., & Kenner, L. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.017 · Cited by 215
Jiang, N., Wang, X., Xie, X., Liao, Y., Liu, N., Liu, J., Miao, N., Shen, J., & Peng, T. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.009 · Cited by 214
Qi, J., Zhou, Y., Jiao, Z., Wang, X., Zhao, Y., Li, Y., Chen, H., Yang, L., Zhu, H., & Li, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479998 · Cited by 191
Self-citationBlocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression
Baglio, S. R., Lagerweij, T., Pérez-Lanzón, M., Ho, X. D., Léveillé, N., Melo, S. A., Cleton-Jansen, A.-M., Jordanova, E. S., Roncuzzi, L., Greco, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2726 · Cited by 187
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
Angulo, P., Kaushik, G., Subramaniam, D., Dandawate, P., Neville, K., Chastain, K., & Anant, S. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0373-z · Cited by 184
Mesenchymal stroma: Role in osteosarcoma progression
Cortini, M., Avnet, S., & Baldini, N. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.024 · Cited by 171
Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression
Chan, L. H., Wang, W., Yeung, W., Deng, Y., Yuan, P., & Mak, K. K. (2014) · Oncogene · doi:10.1038/onc.2013.433 · Cited by 164
Zhou, S., Yu, L., Xiong, M., & Dai, G. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.047 · Cited by 159
Wang, S., Liu, S., Sun, H., Huang, T., Chan, C.-H., Yang, C., Yeh, H., Huang, Y., Chou, W., Lin, Y., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu218 · Cited by 156
Self-citationLiu, L., Li, H., Li, J., Zhong, H., Zhang, H.-C., Chen, J., & Xiao, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.117 · Cited by 150
Avnet, S., Pompo, G. D., Chano, T., Errani, C., Ibrahim‐Hashim, A., Gillies, R. J., Donati, D. M., & Baldini, N. (2016) · International Journal of Cancer · doi:10.1002/ijc.30540 · Cited by 147
McCain, J. (2013) · Europe PMC (PubMed Central) · Cited by 146
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells
Bonuccelli, G., Avnet, S., Grisendi, G., Salerno, M., Granchi, D., Dominici, M., Kusuzaki, K., & Baldini, N. (2014) · Oncotarget · doi:10.18632/oncotarget.2243 · Cited by 140
Vijayakumar, S., Liu, G., Rus, I. A., Yao, S., Chen, Y., Akiri, G., Grumolato, L., & Aaronson, S. A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.010 · Cited by 137
Review of the Molecular Pathogenesis of Osteosarcoma
He, J., Hao, Y. X., Wang, X., Yang, X.-J., Shao, J., Guo, F.-J., & Feng, J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.15.5967 · Cited by 131
Odagiri, H., Kadomatsu, T., Endo, M., Masuda, T., Morioka, M. S., Fukuhara, S., Miyamoto, T. K., Kobayashi, E., Miyata, K., Aoi, J., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004612 · Cited by 130
Zhao, G., Gao, Z., Zhang, Q., Tang, X., Lv, Y., Zhang, Z., Zhang, Y., Tan, Q., Peng, D.-B., Jiang, D., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0856-6 · Cited by 116
Cytogenetics and Molecular Biology of Osteosarcoma
Ragland, B. D., Bell, W. C., Lopez‐Ben, R., & Siegal, G. P. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780431 · Cited by 114
Bone Environment is Essential for Osteosarcoma Development from Transformed Mesenchymal Stem Cells
Rubio, R., Abarrategi, A., García-Castro, J., Martínez-Cruzado, L., Suarez, C. M., Tornín, J., Santos, L. M., Astudillo, A., Colmenero, I., Mulero, F., et al. (2014) · Stem Cells · doi:10.1002/stem.1647 · Cited by 111
Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs
Pradelli, E., Karimdjee-Soilihi, B., Michiels, J., Ricci, J., Millet, M.-A., Burel‐Vandenbos, F., Sullivan, T. J., Collins, T. L., Johnson, M. G., Medina, J. C., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24665 · Cited by 111
Zhang, P., Yang, Y., Nolo, R. M., Zweidler‐McKay, P. A., & Hughes, D. P. M. (2010) · Oncogene · doi:10.1038/onc.2010.62 · Cited by 107
Telangiectatic osteosarcoma: The St. Jude Children's Research Hospital's experience
Weiss, A. R., Khoury, J. D., Hoffer, F. A., Wu, J., Billups, C. A., Heck, R. K., Quintana, J. A., Poe, D., Rao, B. N., & Daw, N. C. (2007) · Cancer · doi:10.1002/cncr.22574 · Cited by 107
Pietrovito, L., Leo, A., Gori, V., Lulli, M., Parri, M., Becherucci, V., Piccini, L., Bambi, F., Taddei, M. L., & Chiarugi, P. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12189 · Cited by 99
Avnet, S., Lemma, S., Cortini, M., Pellegrini, P., Perut, F., Zini, N., Kusuzaki, K., Chano, T., Grisendi, G., Dominici, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11503 · Cited by 98
The role of the bone microenvironment in skeletal metastasis
Zheng, Y., Zhou, H., Dunstan, C. R., Sutherland, R. L., & Seibel, M. J. (2012) · Journal of bone oncology · doi:10.1016/j.jbo.2012.11.002 · Cited by 95
Zhao, H., Hou, W., Tao, J., Zhao, Y., Wan, G., Ma, C., & Xu, H. (2016) · Europe PMC (PubMed Central) · Cited by 94
Jiang, Z., Jiang, C., & Fang, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.012 · Cited by 94
Honoki, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1220 · Cited by 90
Vallabhaneni, K. C., Hassler, M.-Y., Abraham, A., Whitt, J. D., Mo, Y., Atfi, A., & Pochampally, R. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166027 · Cited by 90
Zhao, Z., Jia, Q., Wu, M.-S., Xie, X., Wang, Y., Song, G., Zou, C., Tang, Q., Lu, J., Huang, G., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0692 · Cited by 87
The Bone Microenvironment: a Fertile Soil for Tumor Growth
Buenrostro, D., Mulcrone, P. L., Owens, P., & Sterling, J. A. R. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0315-2 · Cited by 82
Jin, H., Luo, S., Wang, Y., Liu, C., Piao, Z.-H., Xu, M., Guan, W., Li, Q., Zou, H., Tan, Q.-Y., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.008 · Cited by 78
Mutsaers, A. J., Ng, A. J., Baker, E. K., Russell, M. R., Chalk, A. M., Wall, M., Liddicoat, B. J. J., Ho, P. W. M., Slavin, J., Goradia, A., et al. (2013) · Bone · doi:10.1016/j.bone.2013.02.016 · Cited by 76
Lv, Y., Dai, H., Yan, G., Meng, G., Zhang, X., & Guo, Q. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.046 · Cited by 75
Li, Z., Tang, Y., Xing, W., Dong, W., & Wang, Z. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.12.002 · Cited by 75
Yao, Z., Han, L., Chen, Y., He, F., Sun, B., Kamar, S., Zhang, Y., Yang, Y., Wang, C., & Yang, Z. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0647-1 · Cited by 74
Du, L., Han, X.-G., Tu, B., Wang, M.-Q., Qiao, H., Zhang, S.-H., Fan, Q.-M., & Tang, T.-T. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0745-0 · Cited by 70
Wang, C., Zhou, X., Li, W., Li, M., Tu, T., Ba, X., Wu, Y., Huang, Z. D., Fan, G., Zhou, G., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.011 · Cited by 69
Liapis, V., Labrinidis, A., Zinonos, I., Hay, S. J., Ponomarev, V., Panagopoulos, V., DeNichilo, M. O., Ingman, W. V., Atkins, G. J., Findlay, D. M., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.020 · Cited by 64
Vega, O. A., Lucero, C. M. J., Araya, H., Jerez, S., Tapia, J. C., Antonelli, M., Salazar‐Onfray, F., Heras, F. L., Thaler, R., Riester, S. M., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26011 · Cited by 62
Garimella, R., Washington, L., Isaacson, J., Vallejo, J. A., Spence, M., Tawfik, O. W., Rowe, P. S., Brotto, M., & Perez, R. P. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.04.011 · Cited by 60
Kang, H., Park, B.-S., Kang, H., Park, H. R., Yu, S., & Kim, I. (2018) · Environmental Toxicology · doi:10.1002/tox.22548 · Cited by 60
Jerez, S., Araya, H., Hevia, D., Irarrázaval, C. E., Thaler, R., van Wijnen, A. J., & Galindo, M. A. (2019) · Gene · doi:10.1016/j.gene.2019.06.005 · Cited by 60
Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang, M., & Zhang, X. (2015) · PubMed · Cited by 56
Macklin, R., Wang, H., Loo, D., Martin, S., Cumming, A., Cai, N., Lane, R. E., Saenz-Ponce, N., Topkas, E., Inder, K. L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9781 · Cited by 56
Cheng, G., Gao, F., Sun, X., Bi, H., & Zhu, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5663 · Cited by 56
Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion
Nagao‐Kitamoto, H., Setoguchi, T., Kitamoto, S., Nakamura, S., Tsuru, A., Nagata, M., Nagano, S., Ishidou, Y., Yokouchi, M., Kitajima, S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.10.042 · Cited by 55
Wang, X., Liang, X., Liang, H., & Wang, B. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26342 · Cited by 54
Zhang, D., Wang, S., Chen, J., Liu, H., Lu, J., Jiang, H., Huang, A., & Chen, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3921 · Cited by 51
Zhang, Z., Tang, C. Y., Dong, Y., Zhang, J., Yuan, T., Tao, S., & Li, X. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.22249 · Cited by 51
Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma
Lo, W. W., Wunder, J. S., Dickson, B. C., Campbell, V. T., McGovern, K., Alman, B. A., & Andrulis, I. L. (2013) · Cancer · doi:10.1002/cncr.28439 · Cited by 50
The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma
Mohseny, A. B., Cai, Y., Kuijjer, M. L., Xiao, W., van den Akker, B., de Andrea, C. E., Jacobs, R. J., ten Dijke, P., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.018 · Cited by 49
Zhang, S., Liu, L., Lv, Z., Li, Q., Gong, W., & Wu, H. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x14886485417426 · Cited by 49
Ehnman, M., Chaabane, W., Haglund, F., & Tsagkozis, P. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0839-6 · Cited by 49
Xu, E., Zhao, J., Ma, J., Wang, C., Zhang, C., JIANG, H., CHENG, J., Gao, R., & Zhou, X. (2015) · Oncology Reports · doi:10.3892/or.2015.4393 · Cited by 48
Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma
Ren, Z., Liang, S., Yang, J., Han, X., Shan, L., Wang, B., Mu, T., Zhang, Y., Yang, X., Xiong, S., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4352-8 · Cited by 48
Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles
Mannerström, B., Kornilov, R., Abu-Shahba, A. G., Chowdhury, I. M., Sinha, S., Seppänen‐Kaijansinkko, R., & Kaur, S. (2019) · Epigenetics · doi:10.1080/15592294.2019.1585177 · Cited by 48
MicroRNA-20b Downregulates HIF-1α and Inhibits the Proliferation and Invasion of Osteosarcoma Cells
Liu, M., Wang, D., & Li, N. (2016) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14562725373752 · Cited by 47
Zhang, T., Kastrenopoulou, A., Larrouture, Q. C., Athanasou, N. A., & Knowles, H. J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4468-5 · Cited by 47
Lin, S., Zhu, B., Huang, G., Zeng, Q., & Wang, C. (2018) · Human Cell · doi:10.1007/s13577-018-0224-z · Cited by 47
Yang, X., Wang, L., Wang, Q., Li, L., Fu, Y., & Sun, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.170 · Cited by 46
The Emerging Roles of Extracellular Vesicles in Osteosarcoma
Perut, F., Roncuzzi, L., & Baldini, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01342 · Cited by 46
Molecular pathogenesis and therapeutic strategies of human osteosarcoma
Denduluri, S. K., Wang, Z., Yan, Z., Wang, J., Wei, Q., Mohammed, M. K., Haydon, R. C., Luu, H. H., & He, T. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.29.20150075 · Cited by 45
Elevated expression of CXC chemokines in pediatric osteosarcoma patients
Li, Y., Flores, R. J., Yu, A. K.-T., Okcu, M. F., Murray, J. C., Chintagumpala, M., Hicks, J. M., Lau, C. C., & Man, T. (2010) · Cancer · doi:10.1002/cncr.25563 · Cited by 44
Self-citationLiu, J., Tsao, Y.-T., & Hou, C. (2016) · Oncotarget · doi:10.18632/oncotarget.11250 · Cited by 43
PI5P4Kγ functions in DTX1-mediated Notch signaling
Li, Z., & Conner, S. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712142115 · Cited by 43
LINC00968 functions as an oncogene in osteosarcoma by activating the PI3K/AKT/mTOR signaling
Liu, G., Yuan, D., Sun, P., Liu, W., Wu, P., Liu, H., & Yu, G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26624 · Cited by 41
Zhu, X., Zhang, Z.-C., Han, G.-S., Han, J.-Z., & Qiu, D. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6203 · Cited by 36
Yu, X., Wang, Q., Zhou, X., Fu, C., Cheng, M. L., Guo, R., Liu, H., Zhang, B., & Dai, M. (2016) · Oncology Letters · doi:10.3892/ol.2016.5049 · Cited by 34
MicroRNA-26a induces osteosarcoma cell growth and metastasis via the Wnt/β-catenin pathway
Qu, F., LI, C.-B., Yuan, B., Wei, Q., LI, H.-L., SHEN, X.-Z., Zhao, G., WANG, J.-T., & LIU, Y.-J. (2015) · Oncology Letters · doi:10.3892/ol.2015.4073 · Cited by 32
Li, W., He, X., Xue, R., Zhang, Y., Zhang, X., Lu, J., Zhang, Z., & Li, X. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.06.013 · Cited by 32
Nail, L. L., Brennan, M. Á., Rosset, P., Deschaseaux, F., Piloquet, P., Pichon, O., Caignec, C. L., Crenn, V., Layrolle, P., Hérault, O., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030707 · Cited by 32
Salas, S., Jiguet‐Jiglaire, C., Campion, L., Bartoli, C., Frassineti, F., Deville, J., de Paula, A. M., Forest, F., Jézéquel, P., Gentet, J., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-606 · Cited by 30
Кушлинский, Н. Е., Timofeev, Y. S., Solov’ev, Y. N., Gerstein, E. S., Lyubimova, N. V., & Булычева, И. В. (2014) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-014-2605-y · Cited by 28
CXCL8 promotes the invasion of human osteosarcoma cells by regulation of PI3K/Akt signaling pathway
Jiang, H., Wang, X., Miao, W., Wang, B., & Qiu, Y. (2017) · Apmis · doi:10.1111/apm.12721 · Cited by 28
Wang, S., Ren, T., Huang, Y., Bao, X., Sun, K., Shen, D., & Guo, W. (2017) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2017.05.09 · Cited by 26
Lopes, L. J. S., Tesser‐Gamba, F., Petrilli, A. S., Alves, M. T. D. S., Jesús-García, R., & de Toledo, S. R. C. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22619 · Cited by 25
Zhang, Y., Hu, Q., Li, G., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491976 · Cited by 23
Lagerweij, T., Pérez-Lanzón, M., & Baglio, S. R. (2018) · Journal of Visualized Experiments · doi:10.3791/56932 · Cited by 22
Han, W., & Liu, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.049 · Cited by 21
Lan, M., Zhu, X.-P., Cao, Z.-Y., Liu, J.-M., Lin, Q., & Liu, Z.-L. (2018) · Journal of Bone Oncology · doi:10.1016/j.jbo.2018.07.010 · Cited by 19
Neklyudova, O., Arlt, M., Brennecke, P., Thelen, M., Gvozdenovic, A., Kuzmanov, A., Robl, B., Botter, S. M., Born, W., & Fuchs, B. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2185-5 · Cited by 19
CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment
Han, Y. Y., Wu, C., Wang, J., & Liu, N. (2017) · Tumor Biology · doi:10.1177/1010428317701631 · Cited by 11
Lagerweij, T., Pérez-Lanzón, M., & Baglio, S. R. (2018) · Journal of Visualized Experiments · doi:10.3791/56932-v · Cited by 10
Zhao, G., Cai, C., Yang, T., Qiu, X., Liao, B., Li, W., Ji, Z., Zhao, J., Zhao, H., Guo, M., et al. (2013) · PLoS ONE · doi:10.1371/annotation/f47e2af6-da90-40ee-871c-f9ed6f58a48c · Cited by 9
Mapping dysfunction of the bone marrow stroma in leukaemia
Seton-Rogers, S. E. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0165-1 · Cited by 6
Cited by
Zhang, Y., Wang, Y., Zhu, A., Yu, N., Xia, J., & Li, J. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202310252 · Cited by 43
Li, F., Tang, H., Luo, X., Li, X., Luo, K., Liu, S., Liang, J., Liao, S., Zhong, C., Zhan, X., et al. (2023) · Cancer Science · doi:10.1111/cas.15821 · Cited by 22
Metadata
- Authors
- Yang, C., Tian, Y., Zhao, F., Chen, Z., Su, P., Li, Y., & Qian, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-09-23
- Volume
- 21
- Issue
- 19
- Pages
- 6985
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3088618921
- Cited by
- 291
- References
- 115
- FWCI
- 20.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.